3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
226
Lung Neoplasms
78
Neoplasms
37
Mesothelioma
23
Mesothelioma, Malignant
21
Neoplasm Metastasis
20
Breast Neoplasms
18
Adenocarcinoma of Lung
18
Head and Neck Neoplasms
13
Colorectal Neoplasms
13
Parkinson Disease 4, Autosomal Dominant Lewy Body
11
Ovarian Neoplasms
11
Carcinoma
8
Uterine Cervical Neoplasms
6
Non-Squamous Non-Small Cell Lung Cancer
6
Adenocarcinoma, Bronchiolo-Alveolar
6
Adenocarcinoma
6
Unspecified Adult Solid Tumor, Protocol Specific
5
Stomach Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Meningeal Carcinomatosis
5
Brain Neoplasms
5
Urinary Bladder Neoplasms
4
Small Cell Lung Carcinoma
4
Recurrence
4
Prostatic Neoplasms
4
Pancreatic Neoplasms
4
Laryngeal Diseases
4
Endometrial Neoplasms
4
Interventions
Thoracoscopy
2
Cisplatin
2
vandetanib
1
dalotuzumab
1
Ultrasonography
1
Tyrosine Kinase Inhibitors
1
Thoracentesis
1
Pemetrexed
1
Octreotide
1
Gemcitabine
1
Dasatinib
1
Clinical Laboratory Techniques
1
Cdc25C phosphatase (211-221)
1
Catheters, Indwelling
1
Afatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Pleural Effusion
×
Pemetrexed
×
Clear all
NCT00942825
2017-05-24
CBP08-02
CanBas Co. Ltd.
Phase 2
Completed
195 enrolled
8 charts